Wikidata entity: Q11426176
C₂₁H₂₈O₅ (P274)
Quantities
| P4250 | defined daily dose | 10 |
| P2067 | mass | 360.194 |
| P3780 | active ingredient in | ... | Q47521616 (Flo-Pred) | Flo-Pred |
| P3780 | active ingredient in | ... | Q47521941 (Orapred) | Orapred |
| P3780 | active ingredient in | ... | Q47521974 (Pediapred) | Pediapred |
| P3780 | active ingredient in | ... | Q47522011 (Pred Forte) | Pred Forte |
| P3780 | active ingredient in | ... | Q47522012 (Pred Mild) | Pred Mild |
| P3780 | active ingredient in | ... | Q47522290 (Veripred) | Veripred |
| P3780 | active ingredient in | ... | Q48826073 (Omnipred) | Omnipred |
| P3780 | active ingredient in | ... | Q48829125 (Econopred Plus) | Econopred Plus |
| P3780 | active ingredient in | ... | Q48832113 (MILLIPRED) | MILLIPRED |
| P233 | canonical SMILES | String | CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O | ??? |
| P373 | Commons category | String | Prednisolone | ??? |
| P1889 | different from | ... | Q424972 (prednisone) | prednisone |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P527 | has part(s) | ... | Q556 (hydrogen) | hydrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Prednisolone-3D-balls.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O | ??? |
| P2175 | medical condition treated | ... | Q1477 (ulcerative colitis) | ulcerative colitis |
| P2175 | medical condition treated | ... | Q8285 (myasthenia gravis) | myasthenia gravis |
| P2175 | medical condition treated | ... | Q12078 (cancer) | cancer |
| P2175 | medical condition treated | ... | Q52844 (enthesopathy) | enthesopathy |
| P2175 | medical condition treated | ... | Q101991 (inflammation) | inflammation |
| P2175 | medical condition treated | ... | Q167844 (conjunctivitis) | conjunctivitis |
| P2175 | medical condition treated | ... | Q28814 (autoimmune hemolytic anemia) | autoimmune hemolytic anemia |
| P2175 | medical condition treated | ... | Q208414 (lymphoma) | lymphoma |
| P2175 | medical condition treated | ... | Q280027 (uveitis) | uveitis |
| P2175 | medical condition treated | ... | Q504790 (nephrotic syndrome) | nephrotic syndrome |
| P2175 | medical condition treated | ... | Q707816 (giant cell arteritis) | giant cell arteritis |
| P2175 | medical condition treated | ... | Q1138590 (non-Hodgkin lymphoma) | non-Hodgkin lymphoma |
| P2175 | medical condition treated | ... | Q1153419 (interstitial lung disease) | interstitial lung disease |
| P2175 | medical condition treated | ... | Q1161568 (granulomatosis with polyangiitis) | granulomatosis with polyangiitis |
| P2175 | medical condition treated | ... | Q486485 (anasarka) | anasarka |
| P2175 | medical condition treated | ... | Q1363655 (acquired hemophilia) | acquired hemophilia |
| P2175 | medical condition treated | ... | Q1446169 (collagen disease) | collagen disease |
| P2175 | medical condition treated | ... | Q1526459 (pyoderma gangrenosum) | pyoderma gangrenosum |
| P2175 | medical condition treated | ... | Q786844 (autoimmune hepatitis) | autoimmune hepatitis |
| P2175 | medical condition treated | ... | Q949302 (skin disease) | skin disease |
| P2175 | medical condition treated | ... | Q1194520 (graft-versus-host disease) | graft-versus-host disease |
| P2175 | medical condition treated | ... | Q1713037 (membranous glomerulonephritis) | membranous glomerulonephritis |
| P2175 | medical condition treated | ... | Q1752891 (polymyalgia rheumatica) | polymyalgia rheumatica |
| P2175 | medical condition treated | ... | Q1963588 (hematopoietic system disease) | hematopoietic system disease |
| P2175 | medical condition treated | ... | Q2626074 (diffuse large B-cell lymphoma) | diffuse large B-cell lymphoma |
| P2175 | medical condition treated | ... | Q2971524 (eye inflammation) | eye inflammation |
| P2175 | medical condition treated | ... | Q4833719 (B-cell lymphoma) | B-cell lymphoma |
| P2175 | medical condition treated | ... | Q5508825 (functional gastrointestinal disorder) | functional gastrointestinal disorder |
| P2175 | medical condition treated | ... | Q5958765 (hypersensitivity) | hypersensitivity |
| P2175 | medical condition treated | ... | Q3041498 (eye disease) | eye disease |
| P2175 | medical condition treated | ... | Q3931183 (drug reaction with eosinophilia and systemic symptoms) | drug reaction with eosinophilia and systemic symptoms |
| P2175 | medical condition treated | ... | Q980926 (polymyositis) | polymyositis |
| P2175 | medical condition treated | ... | Q1004647 (bullous pemphigoid) | bullous pemphigoid |
| P2175 | medical condition treated | ... | Q17148432 (systemic-onset juvenile idiopathic arthritis) | systemic-onset juvenile idiopathic arthritis |
| P2175 | medical condition treated | ... | Q56014460 (acute graft versus host disease) | acute graft versus host disease |
| P129 | physically interacts with | ... | Q2663095 (Nuclear receptor subfamily 3 group C member 1) | Nuclear receptor subfamily 3 group C member 1 |
| P129 | physically interacts with | ... | Q3454531 (Nuclear receptor subfamily 3 group C member 2) | Nuclear receptor subfamily 3 group C member 2 |
| P129 | physically interacts with | ... | Q21151026 (Glucocorticoid receptor) | Glucocorticoid receptor |
| P3489 | pregnancy category | ... | Q3679189 (Australian pregnancy category A) | Australian pregnancy category A |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P1909 | side effect | ... | Q4340209 (depression) | depression |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q185331 (rocuronium) | rocuronium |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q422618 (ritonavir) | ritonavir |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q27098039 (atracurium) | atracurium |
| P769 | significant drug interaction | ... | Q81978749 (cisatracurium) | cisatracurium |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P9989 | stylized name | String | prednisoLONE | ??? |
| P279 | subclass of | ... | Q177911 (steroid) | steroid |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q422549 (glucocorticoid) | glucocorticoid |
| P2868 | subject has role | ... | Q581996 (anti-inflammatory agent) | anti-inflammatory agent |
| P2868 | subject has role | ... | Q7447768 (selective glucocorticoid receptor agonist) | selective glucocorticoid receptor agonist |
| P2868 | subject has role | ... | Q16909071 (5-lipoxygenase inhibitor) | 5-lipoxygenase inhibitor |
| P2868 | subject has role | ... | Q50430266 (hormonal antineoplastic agent) | hormonal antineoplastic agent |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | prednisolone | ??? |
Why not click here or view trends?
log id: 1960779